Iran's hepatitis elimination programme is under threat Pourkarim, Mahmoud Reza et al. The Lancet , Volume 392 , Issue 10152 , 1009  https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31810-5/fulltext

Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysis. Kranidioti H, Chatzievagelinou C, Protopapas A, Papatheodoridi M, Zisimopoulos K, Evangelidou E, Antonakaki P, Vlachog…

EMCDDA. Viral hepatitis policies in Europe Introduction Hepatitis C virus (HCV) infection is the most common infectious disease in people who inject drugs, among whom it is usually transmitted through the sharing of syringes and other drug us…

European evidence-based guidance on prevention and control of HCV in prison settings (poster) Summary In the 31 EU/EEA countries, more than 590 000 persons are held in a custodial facility on any given day. According to recent reviews of prison st…

Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis Hajarizadeh, Behzad et al. The Lancet Gastroenterology & Hepatology , Volume 0 , Issue 0 , Published:September 20, 20…

Die Leber und Hepatitis C – Das solltest Du wissen Abbvie care, 2018 https://www.abbvie-care.de/content/uploads/2017/12/AbbVieCare_HCV_Fachermagazin_WEB.pdf